Skip to main content

ROAR tests new approach to clinical trials for ALS

Tuesday, May 23, 2017

Rick Bedlack, MD, PhD, is expanding the scope of clinical trials with Replication of ALS Reversals (ROAR), a patient-centric approach to examining connections between alternative therapies and ALS reversals, or extended improvements or pauses in the progression of amyotrophic lateral sclerosis. Cat Lewis  wrote about ROAR in the latest issue of Clinical Practice Today, a free print and monthly publication for clinicians. Read her story here.